Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Aug 12, 2018 8:39pm

183 Views

Post# 28447507

RE:EDT (Spectral Medical)-High Risk High Reward (perhaps)

palinc2000 wrote: If interested read Part 1 to 3 on Stockhouse MB(evaluation)
I do not recommend this stock but one poster is making quite an argument for a multi bagger

Thanks for the referral, but I'm one of those people (frequently referred to on this board) that is OVER-INVESTED in Therf. I'm almost embarrassed with my portfolio pie chart ... that's one big piece of pie!

- LT

Bullboard Posts

Canadians having more difficulty saving for retirement, study finds